Label: CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 1) - BEIGE- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 2) - BEIGE- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 1) - BEIGE- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 2) - BEIGE- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 3) - BEIGE- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 4) - BROWN- octinoxate powder
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (OBSCURE 1) - BROWN- octinoxate powder
-
Contains inactivated NDC Code(s)
NDC Code(s): 13537-482-01, 13537-483-01, 13537-484-01, 13537-485-01, view more13537-486-01, 13537-487-01, 13537-488-01 - Packager: Ventura Corporation LTD
- Category: HUMAN OTC DRUG LABEL
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated November 16, 2019
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active Ingredients
- Purpose
- Uses
- Warnings
- Directions
- Other information
-
Inactive ingredients
MICA, TALC, ZINC STEARATE, BORON NITRIDE, DIMETHICONE, OCTYLDODECANOL, TRIMETHYLSILOXYSILICATE, METHYL METHACRYLATE CROSSPOLYMER, PERFLUOROOCTYL TRIETHOXYSILANE, TOCOPHERYL ACETATE, MAGNESIUM MYRISTATE, PHENOXYETHANOL, CAPRYLYL GLYCOL, FRAGRANCE, CHLORPHENESIN.
MAY CONTAIN:
TITANIUM DIOXIDE, IRON OXIDES. - SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 1) - BEIGE
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (LIGHT 2) - BEIGE
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 1) - BEIGE
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 2) - BEIGE
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 3) - BEIGE
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (MEDIUM 4) - BROWN
- PRINCIPAL DISPLAY PANEL - 7 g Tube Box - (OBSCURE 1) - BROWN
-
INGREDIENTS AND APPEARANCE
CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 1) - BEIGE
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-482 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-482-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (LIGHT 2) - BEIGE
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-483 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-483-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 1) - BEIGE
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-484 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-484-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 2) - BEIGE
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-485 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-485-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 3) - BEIGE
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-486 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-486-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (MEDIUM 4) - BROWN
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-487 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-487-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 CYZONE STUDIO LOOK POLVOS COMPACTOS DE ALTA COBERTURA CON FPS 20 (OBSCURE 1) - BROWN
octinoxate powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:13537-488 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate 0.05 g in 1 g Inactive Ingredients Ingredient Name Strength MICA (UNII: V8A1AW0880) TALC (UNII: 7SEV7J4R1U) ZINC STEARATE (UNII: H92E6QA4FV) BORON NITRIDE (UNII: 2U4T60A6YD) DIMETHICONE (UNII: 92RU3N3Y1O) OCTYLDODECANOL (UNII: 461N1O614Y) PERFLUOROOCTYL TRIETHOXYSILANE (UNII: 814P46684U) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) MAGNESIUM MYRISTATE (UNII: Z1917F0578) PHENOXYETHANOL (UNII: HIE492ZZ3T) CAPRYLYL GLYCOL (UNII: 00YIU5438U) CHLORPHENESIN (UNII: I670DAL4SZ) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) FERRIC OXIDE RED (UNII: 1K09F3G675) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:13537-488-01 1 in 1 BOX 08/24/2015 1 7 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 08/24/2015 Labeler - Ventura Corporation LTD (602751344) Establishment Name Address ID/FEI Business Operations Bel Star S.A. (Colombia) 880160197 MANUFACTURE(13537-482, 13537-483, 13537-484, 13537-485, 13537-486, 13537-487, 13537-488)